Rheumatologists report largely adhering to American College of Rheumatology guidelines for gout management, but show notable ...

and tolerability of serum uric acid lowering and maintenance with febuxostat in patients with gout. Febuxostat Open-label Clinical Trial of Urate-lowering Efficacy and Safety Adverse events were ...

The journey of Takeda’s gout med Uloric—which turned rocky in recent years—has come to an end in the U.S. | Following some ...

Gout affects around one in 40 people in ... Current first-line therapies like allopurinol and febuxostat can be very effective, but some patients – roughly 1% according to FDA estimates ...

current drugs like allopurinol and febuxostat aren’t able to achieve that objective, and there are estimated to be around 160,000 people facing with refractory gout in the US. If approved ...

Zyloprin (allopurinol), Uloric (febuxostat): These drugs are called xanthine oxidase ... This drug is reserved for people who have not had success with other gout medications. Hyperuricemia occurs ...

Eligible for inclusion were adult patients (≥18 years) with microscopically verified gout who initiated or increased ULT (allopurinol, benzbromarone or febuxostat). For the latter group, crystal ...

We studied the proportion of prevalent gout patients who were being consulted specifically for gout or being treated by ULT (allopurinol, febuxostat, benzbromarone, probenecid or sulfinpyrazone) in ...

Among patients with gout in the US, Black individuals and those living in the South were associated with reduced adherence to allopurinol.

Diagnosis Tophaceous gout associated with urate nephropathy in a patient intolerant to allopurinol. Management Acute polyarthritis was successfully managed by intravenous bolus methylprednisolone ...

The drugs listed are in alphabetical order. Bendamustine hydrochloride injection: Apotex on Jan. 27 reported the discontinuation of both the 25 mg and 100 mg presentations of bendamustine ...